Albuminuria: all 142 studies
Page 1 of 2. Open to participants first (24), then studies with results posted, then the rest; newest registration first within each.
- Obesity-Related Indices and Albuminuria in Type 2 DiabetesNot yet recruitingNCT07922694
- Relationship Between Insulin Dose and Complications in Type 1 DiabetesNot yet recruitingNCT07911033
- Study on the Efficacy and Safety of Initial Combination of Finerenone and Semaglutide in Non-Diabetic Adult Patients With Obesity Complicated by Chronic Kidney Disease With AlbuminuriaNot yet recruitingNCT07849348Not applicable
- Systemic Immune-Inflammation Index and Platelet Parameters in Diabetic Kidney DiseaseNot yet recruitingNCT07773467
- Finerenone for Regression of Albuminuria in Type 2 Diabetes With Chronic Kidney DiseaseNot yet recruitingNCT07667517Phase 4
- RAndomized EHR-based Prescribing to Improve Disease-modifying Therapies for Cardio-Kidney-Metabolic Care (RAPID-CKM)Enrolling by invitationNCT07605390Not applicable
- Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)Enrolling by invitationNCT07547878Phase 4
- Optimizing Referral Pathways for Patients With Hematuria and Moderate-Severe ProteinuriaRecruitingNCT07431931Not applicable
- Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Adolescents With Early Stages of Chronic Kidney DiseaseRecruitingNCT07405216Phase 4
- Hypertension in Children and Young People at Risk of Autosomal Dominant Polycystic Kidney DiseaseRecruitingNCT07260071
- FINE-START: Efficacy and Safety of Finerenone in Patients With Chronic Kidney Disease Not Using Renin-angiotensin-system InhibitorsEnrolling by invitationNCT07181135Phase 3
- Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, EmpagliflozinRecruitingNCT07175051Phase 2
- Algae Effects in Markers of Cardiovascular Risk and Gut MicrobiomeRecruitingNCT07173062Not applicable
- Urinary Proteomics to Guide Early Intervention to Prevent Complications in Type 2 Diabetes - a Feasibility StudyEnrolling by invitationNCT06954090Phase 4
- Effect Camostat for Kidney Protection in Chronic Kidney DiseaseRecruitingNCT06794593Phase 2
- Clinical Findings and Albuminuria as Predictors of Acute Kidney Injury in Patients With Acute Heart FailureNot yet recruitingNCT06621862
- The Efficacy and Safety of Sodium-glucose Cotransporter 2 Inhibitors in Patients With Acute Kidney DiseaseRecruitingNCT06528405Phase 2
- Prevention of Chronic Kidney Disease(CDK) Progression in Type 1 Diabetes With Long Term Use of Sodium-Glucose-coTransporter Inhibitors Avoiding Kidney hypOxiaNot yet recruitingNCT06147232Phase 2
- The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR StudyRecruitingNCT06059664Phase 2
- Prevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan AfricaRecruitingNCT05881447
- Effect of Montelukast on Kidney and Vascular Function in Type 1 DiabetesRecruitingNCT05498116Phase 4
- The Predictive Capacity of Machine Learning Models for Progressive Kidney Disease in Individuals With Sickle Cell AnemiaRecruitingNCT05214105
- Diabetic Nephropathy in People With Diabetes. Prevalence and Predictive FactorsRecruitingNCT04916132
- Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)RecruitingNCT04752293
- Efficacy and Safety of Lorundrostat in Addition to Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) in Subjects With Hypertension and Chronic Kidney Disease (CKD) With AlbuminuriaCompletedNCT06150924Phase 2Results posted
- Evaluation of the Accuracy and Usability of the ACR | U.S. Urine Analysis Test System in the Lay User HandsCompletedNCT04626271Not applicableResults posted
- Study Exploring the Effect of Crizanlizumab on Kidney Function in Patients With Chronic Kidney Disease Caused by Sickle Cell DiseaseCompletedNCT04053764Phase 2Results posted
- SIKAMIC (SIklos on Kidney Function and AlbuMInuria Clinical Trial)CompletedNCT03806452Phase 2Results posted
- Five, Plus Nuts and Beans for KidneysCompletedNCT03299816Not applicableResults posted
- Omega 3 Fatty Acids in Patients With Chronic Renal DiseaseCompletedNCT03280615Phase 3Results posted
- Optimal Management of HIV Infected Adults at Risk for Kidney Complications in NigeriaTerminatedNCT03201939Phase 2Results posted
- Intensive Uric Acid Lowering With Verinurad and Febuxostat in Patients With AlbuminuriaCompletedNCT03118739Phase 2Results posted
- GLP-1 Receptor Agonist Therapy and Albuminuria in Patients With Type 2 DiabetesTerminatedNCT03029351Phase 4Results posted
- A Study to Evaluate the Effect of Dapagliflozin With and Without Saxagliptin on Albuminuria, and to Investigate the Effect of Dapagliflozin and Saxagliptin on HbA1c in Patients With Type 2 Diabetes and CKDCompletedNCT02547935Phase 2/3Results posted
- Vascular Effects of Mineralocorticoid Receptor Antagonism in Kidney DiseaseCompletedNCT02497300Phase 2Results posted
- Study of Dietary Additive Phosphorus on Proteinuria and Fibroblast Growth Factor-23CompletedNCT02020785Not applicableResults posted
- Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and AlbuminuriaCompletedNCT02010242Phase 2Results posted
- A Study of the Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Diabetes MellitusCompletedNCT01989754Phase 4Results posted
- A Study in CKD Patients With Type 2 Diabetes Mellitus and AlbuminuriaCompletedNCT01847092Phase 2Results posted
- Effect of Atorvastatin on Endothelial Dysfunction and Albuminuria in Sickle Cell DiseaseCompletedNCT01732718Phase 2Results posted
- A Phase 2 Multi-Center Study To Evaluate The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist In Adults With Type 2 Diabetes And Overt NephropathyCompletedNCT01712061Phase 2Results posted
- Vitamin D and Omega-3 Trial to Prevent and Treat Diabetic Kidney DiseaseCompletedNCT01684722Not applicableResults posted
- Effects of Low Sodium Intake on the Anti-proteinuric Efficacy in Hypertensive Patient With OlmesartanCompletedNCT01552954Phase 4Results posted
- Shiga Microalbuminuria Reduction Trial-2CompletedNCT01461499Phase 4Results posted
- Rhubarb and Angiotensin Converting Enzyme InhibitorTerminatedNCT00672451Phase 2Results posted
- Tetrahydrobiopterin in Patients With Chronic Kidney Disease (CKD) and AlbuminuriaCompletedNCT00625820Phase 2Results posted
- Does Thiazolidinedione Therapy Improve Endothelial Function and Preserve Renal FunctionTerminatedNCT00586261Not applicableResults posted
- Randomized Controlled Trial of Vitamin D3 in Diabetic Kidney DiseaseCompletedNCT00552409Phase 2/3Results posted
- Effect of Sulodexide in Early Diabetic NephropathyCompletedNCT00130208Phase 3Results posted
- Mesenchymal Stem Cell Exosomes Alone or Combined With HUVEC Exosomes in Non-Dialysis Chronic Kidney DiseaseCompletedNCT07922889Phase 1/2
- A Study on the Safety and Clinical Efficacy of Guominkang in the Treatment of Diabetic Kidney DiseaseActive, not recruitingNCT07907965Phase 2
- Comparing The Effect Of Empagliflozin With Dapagliflozin In Reducing Proteinuria In Diabetic Patients With Chronic Kidney Disease With eGFR More Than 45ml/Min/1.73m²CompletedNCT07866235Not applicable
- Safety and Efficacy of the Combination Therapy of Fucoidan / Fucoxanthin / L-carnitine in Patients With Diabetic Nephropathy.CompletedNCT07804641Phase 2
- Rubix LS Diabetic Kidney Disease (DKD) Registry StudyActive, not recruitingNCT07348718
- The Effect of Combined Dulaglutide and Dapagliflozin Treatment vs DPP-4 Inhibitors in Endothelial and Vascular Function in Patients With Type 2 Diabetes Mellitus and AlbuminuriaActive, not recruitingNCT06611904Not applicable
- Treating Metabolic Acidosis in Chronic Kidney Disease to Prevent Adverse Kidney and Cardiovascular OutcomesCompletedNCT06545461Not applicable
- Albuminuria Lowering Effect of Dapagliflozin, Spironolactone and Their Combination in Adult Patients With Alport Syndrome (COMBINE-ALPORT)CompletedNCT06499948Phase 4
- Decentralized N=1 Study: A Feasible Approach to Evaluate Individual Therapy Response to Dapagliflozin.CompletedNCT06374043Phase 4
- Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical TrialCompletedNCT06094920Phase 4
- Dietary Acid Reduction and Progression of Chronic Kidney DiseaseCompletedNCT06046924Not applicable
- Evaluation of the Accuracy and Usability of the Minuteful - Kidney Urine Analysis Test System in the Lay User HandsCompletedNCT05838872Not applicable
- Real Clinical Practice Register of AlbUminuRia Detection in Patients With Previously undiAgnosed Chronic Kidney DiseaseCompletedNCT05690009
- Zibotentan and Dapagliflozin in Patients With Type 2 Diabetes and Elevated AlbuminuriaCompletedNCT05570305Phase 2
- Screening for Albuminuria at the First Line for Early Identification of CKDCompletedNCT05321095
- Dietary Intervention in Obesity-related GlomerulopathyStatus unknownNCT05294770Not applicable
- KidneYou - Innovative Digital TherapyCompletedNCT05286632Not applicable
- TreatIng Microalbuminuria Over 24 Weeks in Subjects With or Without Type 2 Diabetes or HYpertensionTerminatedNCT05268926Phase 2
- Cardiorenal Effecs of Losartan in Kidney Transplant RecipientsStatus unknownNCT05243446
- To Improve the Ability of Early Screening and Diagnosis in Patients With Diabetic NephropathyStatus unknownNCT05047471
- Effect of Empagliflozin on Urinary Excretion of Adenosine and Osteocyte Function in Patients With Chronic Kidney DiseaseStatus unknownNCT04961931Not applicable
- SeMaglutide and Albuminuria Reduction Trial in Obese Individuals Without DiabetesCompletedNCT04889183Phase 3
- SER150 vs Placebo in Diabetic Kidney DiseaseCompletedNCT04881123Phase 2/3
- Effects of Probiotics and Fibers on Albuminuria in Persons With Type 1 DiabetesCompletedNCT04635670Not applicable
- Effects of Rehydration During Physical Exercise on Acute Kidney Injury BiomarkersStatus unknownNCT04310514Not applicable
- Towards HOMe-based Albuminuria Screening: an Implementation Study Testing Two ApproachesStatus unknownNCT04295889Not applicable
- Substitution of Sulfonylureas With New Generation of Hypoglycemic Drugs for the Treatment of Type 2 Diabetes MellitusStatus unknownNCT04272359
- Effects of SGLT2 Inhibition Treatment on Different Levels of Albuminuria in Patients With Type 2 DiabetesStatus unknownNCT04127084Phase 4
- Effect of Butyrate on Inflammation and Albuminuria in Patients With Albuminuria, Type 1 Diabetes and Intestinal InflammationStatus unknownNCT04073927Not applicable
- Dietary Interventions on Glycocalyx Dimensions in South Asian Patients With Diabetic Nephropathy.CompletedNCT03889236Not applicable
- Effect of Evogliptin on Albuminuria in Patients With Type 2 Diabetes and Renal InsufficiencyCompletedNCT03667300Phase 2
- Association Between Phthalates Exposure and Renal Function Impairment in TYpe 2 DiabetesStatus unknownNCT03622957
- Improving Albuminuria Screening Compliance Using a Smartphone Urinalysis KitCompletedNCT03470701Not applicable
- Arrhythmias, Microalbuminuria and CorticosteroidsCompletedNCT03453931
- Effects of Intensive Low-Salt Diet Education by Mobile Application on AlbuminuriaCompletedNCT03396328Not applicable
- World Trade Center Kidney-LinkCompletedNCT03234530
- Facilitating Improvements in Kidney Health Using a Smartphone App Counseling Program in Patients With DiabetesCompletedNCT03015480Not applicable
- Sodium Lowering and Urinary Protein Reduction TrialCompletedNCT02945969Phase 3
- Effects of Dapagliflozin Treatment on Urinary Proteomic Patterns in Patients With Type 2 DiabetesCompletedNCT02914691Phase 4
- Microalbuminuria and Allopurinol in Type 1 DiabetesCompletedNCT02829177Phase 4
- CPAP Effect on Albuminuria in Patients With Diabetic Nephropathy and Obstructive Sleep ApneaCompletedNCT02816762Phase 4
- Study of CS-3150 in Hypertensive Patients With Type 2 Diabetes and AlbuminuriaCompletedNCT02807974Phase 3
- Resveratrol's Effects in Diabetic NephropathyCompletedNCT02704494Early Phase 1
- Effect of Pirfenidone on Glomerular Filtration Rate and Albuminuria in Patients With Diabetic NephropathyCompletedNCT02689778Phase 3
- Influence of Aliskiren on Albuminuria After Kidney TransplantationCompletedNCT02446548Not applicable
- Accuracy of Glomerular Filtration Rate (GFR) Estimation Using Creatinine and Cystatin C and AlbuminuriaStatus unknownNCT02433002
- Effect of Ambulatory BP Monitoring on the CliniCal coUrse and RenAl ouTcomE of CKDStatus unknownNCT02417571Not applicable
- Effects of Linagliptin on Endothelial- , Renal-, and Retinal Function in Patients With Hypertension and AlbuminuriaCompletedNCT02376075Phase 3
- Micro-Particle Curcumin for the Treatment of Chronic Kidney DiseaseCompletedNCT02369549Phase 3
- World Trade Center (WTC) RENALCompletedNCT02246101
- Early Identification and Action in CKDCompletedNCT02208674Not applicable